Seven patents currently held, every record listed here

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in May 2039. from the record

Free plan: 3 watched companies. Pro: unlimited.

Alerts on its grants, lapses and transfers.

Ending by 2030

May 2039

Next term end

Patent families

When these terms end

Each bar runs from grant to computed term end. 2022 to 2044.

US 11,295,261 Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems May 28, 2039

US 11,531,949 Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems no later than May 28, 2039

US 11,790,298 Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems no later than May 28, 2039

US 12,190,271 Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems May 28, 2039

US 11,955,232 Immersive Medicine Translational Engine for Development and Repurposing of Non-Verified and Validated Code Sep 24, 2041

US 12,525,344 Immersive Medicine Translational Engine for Development and Repurposing of Non-Verified and Validated Code Feb 6, 2042

US 12,746,377 Dynamically Controlled Cerebrospinal Fluid Shunt Mar 21, 2044

20272032203720422044

A dotted end marks a recorded terminal disclaimer this site has not resolved: the term can only be shorter than the bar, never longer.

8 pending applications: term is not computable until grant.Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank

Only 2 of the currently held patents qualify as notable.

Notable

Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems US 11,295,261

The most cited patent in this portfolio, cited by 27 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2039.

Ends May 2039 · High confidence Also notable

Dynamically Controlled Cerebrospinal Fluid Shunt US 12,746,377

Granted 2026. Too new for citation comparison; protection runs to 2044.

Ends Mar 2044 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Apr 17, 2027
The maintenance fee for Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems (US 11,790,298) comes due Apr 17, 2027. Unpaid by Oct 18, 2027, it lapses early.
1 fee due Oct 9, 2027
The maintenance fee for Immersive Medicine Translational Engine for Development and Repurposing of Non-Verified and Validated Code (US 11,955,232) comes due Oct 9, 2027. Unpaid by Apr 10, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 of the patents on this record was granted since Aug 17, 2026

What they patent

The 1 largest of its 2 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems

6 in force

to Feb 2042

Patents held now

Soonest term end first.

Showing 1 to 7 of 7

Patent	Title	Status	Expires	Confidence
US 11,295,261	Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems In force Term ends May 28, 2039 · High confidence	In force	Term ends May 28, 2039	High confidence
US 11,531,949	Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems In force Ends no later than May 28, 2039 · Medium confidence	In force	Ends no later than May 28, 2039	Medium confidence
US 11,790,298	Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems In force Ends no later than May 28, 2039 · Medium confidence	In force	Ends no later than May 28, 2039	Medium confidence
US 12,190,271	Fda Compliant Quality System to Risk-Mitigate, Develop, and Maintain Software-Based Medical Systems In force Term ends May 28, 2039 · Medium confidence	In force	Term ends May 28, 2039	Medium confidence
US 11,955,232	Immersive Medicine Translational Engine for Development and Repurposing of Non-Verified and Validated Code In force Term ends Sep 24, 2041 · High confidence	In force	Term ends Sep 24, 2041	High confidence
US 12,525,344	Immersive Medicine Translational Engine for Development and Repurposing of Non-Verified and Validated Code In force Term ends Feb 6, 2042 · High confidence	In force	Term ends Feb 6, 2042	High confidence
US 12,746,377	Dynamically Controlled Cerebrospinal Fluid Shunt In force Term ends Mar 21, 2044 · High confidence	In force	Term ends Mar 21, 2044	High confidence

Also on record, not counted in the 7: 8 applications pending. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built

Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

2 terminal disclaimers are on file with no resolved reference. No cap is applied and none is guessed

Export every term end as CSV · Pro

Oaya, Inc.